IDMI

QualityStocks: QualityStocks News - IDM Pharma Inc.aEUR(TM)s (IDMI) Childhood Bone Tumor Treatment Gains Positive Review, Marketing Recommendation by European Medicines Agency - 11/19/08 - 11/20 - 04:05 AM ET

XplosiveStocks.com: IDM Pharma, Inc. (Nasdaq: IDMI) Hot Stock on the Move! - 11/19 - 03:48 AM ET

IDM Pharma Advances After Having Mifamurtide Recommended For Approval In Europe - 11/18 - 04:26 PM ET

UPDATE 1-EU agency backs IDM Pharma's bone cancer drug; shrs up - 11/18 - 11:54 AM ET

IDMI: EU Committee Recommendation for Approval of Mifamurtide - 11/18 - 08:38 AM ET

IDM Pharma Receives Recommendation for Approval of Mifamurtide (MEPACT(R), L-MTP-PE) for the Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma in Europe from the Committee for Medicinal Products for Human Use (CHMP) - 11/18 - 07:30 AM ET

BRIEF-IDM Pharma Q3 results - 11/13 - 07:58 AM ET

IDM Pharma Reports Third Quarter Financial Results - 11/13 - 07:30 AM ET

Horizon Therapeutics names new CFO - 10/10 - 09:56 AM ET

Horizon Therapeutics Names Robert J. De Vaere Executive Vice President and Chief Financial Officer - 10/09 - 08:00 AM ET

IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) - 09/26 - 07:00 AM ET

IDM Pharma Picks Up Volume, Jumps To Multi-Month High - 08/27 - 12:03 PM ET

IDM Pharma Reports Second Quarter Financial Results - 08/07 - 07:30 AM ET

Horizon Therapeutics names new president and CEO - 07/25 - 12:05 PM ET

IDM Pharma: CHMP requests additional data analyses from Phase III L-MTP-PE trial - 07/01 - 07:46 AM ET

IDM PHARMA: EXPECTS TO COMPLETE ADDL ANALYSES BY END OF AUGUST - 07/01 - 07:36 AM ET

IDM PHARMA: EXPECTS EXPECTS ISSUE RESOLUTION IN 3Q FOR MARKETING AUTHORIZATION - 07/01 - 07:36 AM ET

IDM PHARMA: CHMP REQUESTS ADDL DATA ANALYSES FROM PHASE 3 TRIAL OF MIFAMURTIDE - 07/01 - 07:35 AM ET

IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP) - 07/01 - 07:30 AM ET

IDM PHARMA GAINS 11%; POSITIVE RESULTS IN PHASE II STUDY FOR IDM-2101 - 06/02 - 10:33 AM ET

Page 1 of 5     1  2   3   4   5      Previous  |  Next

<< Back to Stock Index